Tunnicliffe, David J; Palmer, SC; Henderson, L; Henderson, L; Masson, P; Craig, JC; Tong, A; Singh-Grewal, D; Flanc, RS; Roberts, MA; Webster, AC; Strippoli, GFM (John Wiley & Sons, Ltd., 2018)
Background
Cyclophosphamide, in combination with corticosteroids, has been first-line treatment for inducing disease remission for proliferative lupus nephritis, reducing death at five years from over 50% in the 1950s and ...
